Email ID : 
Password : 
Forgot Your Password ? 

Only Report Titles
Titles & Keywords
NOTE: Site best viewed with Internet Explorer
  PEPTIC ULCER TESTING
A Global Strategic Business Report

This report analyzes the worldwide markets for Peptic Ulcers Testing in Millions of US$. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual forecasts are provided for each region for the period of 2001 through 2015. A ten-year historic analysis is also provided for these markets with annual market analytics. The report profiles 29 companies including many key and niche players worldwide such as Beckman Coulter Inc., Kibion AB, Meretek Diagnostics Group of Otsuka America Pharmaceutical, Inc., Meridian Bioscience, Inc., Orion Diagnostica Oy, and Quidel Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CODE:    MCP-3417  PAGES:    150
PRICE:    $3450  DATE:       March 2008
COMPANIES:  29  MARKET DATA TABLES:   45
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

 TABLE OF CONTENTS  
  PEPTIC ULCER TESTING (Complete Report) Pages : 150   | $3450
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS4$100
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
CAGR Disparities Between Historic & Current Data.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
  
   Peptic Ulcer Tests.....I-4  
II. EXECUTIVE SUMMARY34$1950
  1. Industry Highlights.....II-11 $100  
   Industry Highlights.....II-1
1$100
  2. Peptic Ulcers - A Prelude.....II-21 $100  
   Peptic Ulcers - A Prelude.....II-2
1$100
  3. Classification of Peptic Ulcers.....II-32 $200  
   Gastric Ulcers.....II-3
Duodenal Ulcers.....II-3
Bleeding Peptic Ulcers.....II-3
2$200
  4. Conditions or Causes of Peptic Ulcers.....II-52 $200  
   H. Pylori: The Major Cause of Peptic Ulcers.....II-5
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).....II-5
1$100
   Excess Acid Production in the Stomach.....II-6
1$100
  5. Discovery of H. Pylori - Paradigm Change in Ulcer Treatment.....II-72 $200  
   H. Pylori – Most Harmful Class I Carcinogen.....II-7
Diseases Caused by H. Pylori Infection.....II-7
1$100
   Transmission of H. Pylori.....II-8
Eradication of H. Pylori.....II-8
1$100
  6. Peptic Ulcer Tests.....II-99 $700  
   Testing for the Presence of H. Pylori.....II-9
Diagnostic Assays for Detection of H. Pylori.....II-9
1$100
   Invasive Tests.....II-10
Non-Invasive Tests.....II-10
Tissue Tests: Endoscopy of the Stomach.....II-10
Gastrointestinal Endoscopy: Gold Standard in Diagnoses of Upper GI Diseases.....II-10
The Endoscopic Procedure.....II-10
1$100
   Blood Test or Serological Test.....II-11
Types of Blood Tests.....II-11
Urea Breath Test (UBT) – The Most Effective Diagnoses for Detection of H.
  Pylori.....II-11
1$100
   Urea Breath Test: A Convenient and Affordable Method for Detection & Treatment of
  Peptic Ulcer.....II-12
Types of Urea Breath Tests.....II-12
Carbon-14-Urea Breath Test.....II-12
Precautionary Measures to be taken Prior to Performance of UBT.....II-12
1$100
   Federal Legislation Governing the 14C UBT.....II-13
Carbon-13-Urea Breath Test.....II-13
Breath Tests Vs Other Diagnostic Assays.....II-13
Barium X-rays.....II-13
1$100
   Noster System AB’s BreathCard™ and Heliprobe™ Systems.....II-14
Other Diagnostic Devices and Tests.....II-14
FlexSure. HP.....II-14
1$100
   QuickView.....II-15
CLOtest.....II-15
CLOser.....II-15
Automated Breath 13C Analyzer (ABCA).....II-15
1$100
   Helicobacter Pylori Detection Via 13C-UBT.....II-16
Pytest .....II-16
MicroCOUNT.....II-16
EZ-H.P. - The 10 Minute Ulcer Screening Test.....II-16
The Single-Step H. Pylori Test.....II-16
1$100
   Helisal ™ Rapid Blood Test.....II-17
1$100
  7. Treatment of Peptic Ulcers.....II-183 $300  
   Perplexity of Ulcers.....II-18
A New Page Opens in the Treatment of Ulcers.....II-18
Factors Affecting Peptic Ulcer Conditions.....II-18
Ulcer Therapies for Preventing PUD Recurrence: A Review.....II-18
1$100
   Advanced-Generation Macrolide Antibiotic Biaxin Therapy.....II-19
The Two-Week Double and Triple Therapies.....II-19
Medication.....II-19
H2-blockers.....II-19
1$100
   Acid Pump Inhibitors.....II-20
Mucosal Protective Medications.....II-20
1$100
  8. Drugs Used to Cure Non-Steroidal Anti- Inflammatory Drug (NSAID) Induced
  Ulcers.....II-21
1 $100  
   Handling NSAID-Induced Ulcers.....II-21
Antacids.....II-21
Antibiotics.....II-21
Side Effects Associated with Antibiotics.....II-21
Misoprostol.....II-21
Cimetidine.....II-21
Mucosta.....II-21
Sucralfate (Carafate).....II-21
1$100
  9. The Need for Surgery.....II-221 $100  
   The Need for Surgery.....II-22
1$100
  10. Research & Development.....II-231 $100  
   Probiotics’ Effectiveness in Peptic Ulcer Treatment.....II-23
Peptic Ulcer – Relation with Oral Hygiene.....II-23
PPIs Relegate Peptic Ulcer Bleeding.....II-23
1$100
  11. Product Innovations/Introductions.....II-242 $200  
   Sanko Junyaku to Introduce Diagnostic Kit for H. pylori Infection.....II-24
Torrent Pharmaceuticals Releases Nexpro Fast.....II-24
Wyeth Laboratories Launches HeliMet Triple Pack.....II-24
AstraZeneca Introduces Nexium.....II-24
Biomerica Launches Pepgen Test.....II-24
1$100
   Norton Healthcare Introduces Famotidine Tablets.....II-25
1$100
  12. Recent Industry Activity.....II-263 $300  
   Meretek Strikes Deal with PAML.....II-26
Meretek Diagnostics and OAPI Announce Merger.....II-26
Meridian’s Partnership with Merck KGaA.....II-26
Meridian Bags FDA Clearance for Stomach Ulcer Test.....II-26
Kibion AB Acquires Noster System.....II-26
1$100
   Takeda Pharmaceutical Bags Additional Approval for Takepron.....II-27
UCB’s Licensing Agreement with Boryung.....II-27
Eisai and GlaxoSmithKline Sign Co-marketing Agreement.....II-27
Yuhan Gains KFDA Approval for Duodenal Ulcers’ Drug.....II-27
Yamanouchi Signs Agreement with Aventis Pharma.....II-27
Oridion Bags FDA Clearance for BreathID® H. Pylori Breath Test.....II-27
1$100
   Quidel Corporation Unveils Latest Version of H. Pylori Test.....II-28
Teikoku Chemical Licenses Technology to Eisai.....II-28
Trinity Biotech Bags FDA Clearance for Uni-Gold™ Test.....II-28
EPI Bags FDA Clearance for PP-CAP® IgA EIA.....II-28
1$100
  13. Focus on Select Global Players.....II-292 $200  
   Beckman Coulter, Inc. (USA).....II-29
Kibion AB (Sweden).....II-29
Meretek Diagnostics Group of Otsuka America Pharmaceutical, Inc. (USA).....II-29
Meridian Bioscience, Inc. (USA).....II-29
1$100
   Orion Diagnostica Oy (Finland).....II-30
Quidel Corporation (USA).....II-30
1$100
  14. Global Market Perspective.....II-31   
   Table 1: World Recent Past, Current & Future Analysis for Peptic Ulcer Testing by Geographic Region – USA, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....II-311$300
   Table 2: World Long Term Projections for Peptic Ulcer Testing by Geographic Region – USA, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) .....II-321$300
   Table 3: World Historic Review for Peptic Ulcer Testing by Geographic Region – USA, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....II-331$300
   Table 4: World 15-Year Perspective for Peptic Ulcer Testing by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008, & 2012 (includes corresponding Graph/Chart).....II-341$300
III. MARKET20$1650
  1. The United States.....III-16 $520  
   A. Market Analysis.....III-1
Current and Future Analysis.....III-1
Product Launches/Developments.....III-1
1$90
   Strategic Corporate Developments.....III-21$90
   Key Players.....III-32$180
   B. Market Analytics.....III-5
Table 5: US Recent Past, Current & Future Analysis for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-5

Table 6: US Long Term Projections for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) .....III-5
1$150
   Table 7: US Historic Review for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....III-6
1$150
  2. Japan.....III-73 $270  
   A. Market Analysis.....III-7
Current and Future Analysis.....III-7
Strategic Corporate Developments.....III-7
Product Launch.....III-7
1$90
   B. Market Analytics.....III-8
Table 8: Japanese Recent Past, Current & Future Analysis for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-8

Table 9: Japanese Long Term Projections for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) .....III-8
1$150
   Table 10: Japanese Historic Review for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....III-9
1$150
  3. Europe.....III-104 $340  
   A. Market Analysis.....III-10
Current and Future Analysis.....III-10
Product Launch.....III-10
Strategic Corporate Development.....III-10
1$90
   Key Players.....III-111$90
   B. Market Analytics.....III-12
Table 11: European Recent Past, Current & Future Analysis for Peptic Ulcer Testing Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-12

Table 12: European Long Term Projections for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) .....III-12
1$150
   Table 13: European Historic Review for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....III-13
1$150
  4. Asia-Pacific.....III-143 $270  
   A. Market Analysis.....III-14
Current and Future Analysis.....III-14
Product Launch.....III-14
Strategic Corporate Developments.....III-14
1$90
   B. Market Analytics.....III-15
Table 14: Asia-Pacific Recent Past, Current & Future Analysis for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-15

Table 15: Asia Pacific Long Term Projections for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) .....III-15
1$150
   Table 16: Asia-Pacific Historic Review for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....III-16
1$150
  5. Latin America.....III-172 $180  
   Market Analysis.....III-17
Current and Future Analysis.....III-17
Table 17: Latin America Recent Past, Current & Future Analysis for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-17
1$150
   Table 18: Latin America Long Term Projections for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) .....III-18

Table 19: Latin America Historic Review for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....III-18
1$150
  6. Rest of World.....III-192 $300  
   A. Market Analysis.....III-19
Current and Future Analysis.....III-19
Strategic Corporate Development.....III-19
B. Market Analytics.....III-19
Table 20: Rest of World Recent Past, Current & Future Analysis for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....III-19
1$150
   Table 21: Rest of World Long Term Projections for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) .....III-20

Table 22: Rest of World Historic Review for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart).....III-20
1$150
IV. COMPETITIVE LANDSCAPE 81$995
  
Total Companies Profiled: 29 (including Divisions/Subsidiaries - 31)

Region/Country                 Players

The United States                 18
Canada                             1
Japan                              x
Europe                            11 
     France                        x
     Germany                       x
     The United Kingdom            x
     Italy                         x
     Spain                         x
     Russia                        x
     Rest of Europe               11 
Asia-Pacific (Excluding Japan)     1
Middle East                        x
Latin America                      x
Click here to request a full table of contents and more details on this project.		  
 
 
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

© Copyrights 2009, Global Industry Analysts, Inc., USA.